Developing innovative sensor technology to support the future of intravenous therapy monitoring in vulnerable patient populations
IMPORTANT NOTICE: Rely-V™ is an investigational technology currently under development and pre-clinical evaluation. It is NOT a certified medical device, NOT CE marked, and NOT available for clinical use or sale. The technology may not be used in any clinical setting. All descriptions reflect our development objectives and are subject to regulatory approval and clinical validation.
In neonatal and pediatric intensive care, the prevalence of flow rate errors in over 60% of IV infusions poses serious risks for vulnerable patients. Factors like occlusions and multi-infusion dynamics contribute to interruptions in flow continuity, as acknowledged by the FDA. Particularly concerning are the delays in detecting flow changes at extremely low infusion rates (< 1 mL/hr) in NICUs and PICUs, increasing the likelihood of adverse drug events and potential harm to fragile patients. Our research focuses on developing technology related to these clinical challenges.
Rely-V™ represents our sensor technology research program focused on the technical challenges of low-flow fluid dynamics in medical applications. Our development work explores advanced microelectromechanical systems (MEMS) sensor architectures and signal processing methodologies.
Current status: Technology Readiness Level 4 This technology is in the (pre-clinical development phase). This technology is not a medical device, has not received CE marking, and is not available for clinical use.
Research and Development Focus Areas:
Our development explores optimal sensor placement geometries in fluid systems.
Research into real-time data acquisition and treshold detection algorithms.
Development of modular sensor designs utilizing non-invasive measurement approaches.
Sencilia, founded in September 2021, spun out from the University of Groningen with the mission to enhance the safety of IV infusion therapy for vulnerable patients. Our innovative flow sensor technology is being developed in collaboration with renowned partners such as Erasmus Medical Center and the University Medical Center Groningen. We are currently developing Rely-V™ technology, with the vision of becoming the standard of care in IV infusion therapy by 2030.
